Sentien Biotechnologies, Inc. Announces Initial Round of Financing

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Biotechnologies, Inc. Announces Initial Round of Financing

Sentien Biotechnologies, Inc., a regenerative medicine company developing cell based therapies for acute organ failure, is pleased to announce an initial round of financing by Boehringer Ingelheim Venture Fund USA, Inc. and Portage Biotech Inc.
LEARN MORE >